Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

Introducing the OTC gene improved symptoms in mice with OTC deficiency.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Citrate is a safer alternative to heparin for preventing blood clots in hemodialysis.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Ritlecitinib is effective and safe for treating alopecia areata, especially in newer cases.

GI197111X is best dissolved in Capmul MCM for trials.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Stress hormone CRF causes hair loss and stops hair cell growth.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

A new topical treatment may prevent hair loss from cancer therapy by adjusting cell death processes in hair follicles.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

A new genetic mutation in the TRPS1 gene causes Trichorhinophalangeal Syndrome, leading to specific hair, dental, and bone issues.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Stress hormone CRF causes hair loss and inhibits hair growth in human cells.

Clinicians should consider individual factors and communicate risks and benefits when prescribing ritlecitinib for adolescent alopecia areata.

Two patients treated with TAC for mouth fibrosis improved but developed Cushing's Syndrome symptoms.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

LHTric-1 is a specific antibody useful for studying hair and nail formation.